Big Pharma Earnings Watch: Abbvie

11-1-2019 Blog Posts

Brand Name Drug Giant Completes Sweep of Big Pharma Companies Who Beat Expectations After Hiking Prices Earnings reports for the third quarter of the year provide the latest evidence that Big Pharma continues to bank record profits while price-gouging American patients. Today, brand name drug giant AbbVie announced better than expected earnings after a year […]


10-31-2019 Blog Posts

Good Times Rolling for Brand Name Drug Makers, Two More Top Earnings Forecasts After Increasing Prices Two more brand name giants – Bristol-Myers Squibb and Sanofi – topped earnings expectations while continuing to hike prices on vulnerable patients. The pair keep a trend alive that’s been consistent for all nine of the world’s largest pharmaceutical […]

Big Pharma Earnings Watch: Glaxosmithkline and Amgen

10-30-2019 Blog Posts

Big Pharma’s Earnings Keep Rising Off of Price Hikes To no one’s surprise, two more brand name drug manufacturers, GlaxoSmithKline (GSK) and Amgen both topped earnings expectations for the third quarter of 2019 this week after hiking prices on their products earlier this year. Of the Big Pharma giants who have announced Q3 earnings so […]

Big Pharma Watch: Merck and Pfizer

10-29-2019 Blog Posts

Two More Big Pharma Giants Beat Q3 Forecasts After Hiking Prices On Cancer And Arthritis Drugs Kicking off the final week of Q3 earnings reports, two more brand name giants – Merck and Pfizer – both “easily” beat Wall Street expectations after hiking prices on American patients earlier this year. Merck Merck reported $12.4 billion […]

Big Pharma Earnings Watch: Eli Lilly

10-24-2019 Blog Posts

Pharmaceutical Giant Beats Q3 Profit Forecasts After Hiking Prices on Drugs Used to Treat Diabetes and Cancer Yesterday, Eli Lilly joined fellow Big Pharma giants Johnson & Johnson, Roche and Novartis in surpassing earnings expectations for the third quarter of 2019 — after continuing to hike prices on its medications despite the rising crisis of […]

Big Pharma Earnings Watch: Astrazeneca

10-24-2019 Blog Posts

Another Brand Name Drug Maker Beats Expectations After Raising Prices Rounding out this week’s reporting on third quarter earnings, Big Pharma giant AstraZeneca joined four other brand name giants in beating expectations after raising prices on their products earlier this year. AstraZeneca reported $6.1 billion in revenue, beating expectations of $5.8 billion. The company raised […]


10-22-2019 Blog Posts

Drug Makers Score Big Off of Price Hikes, Sky-High Launch Prices As Americans continue to struggle to afford their prescription drug medications, earnings announcements from brand name drug giants Johnson & Johnson, Roche and Novartis demonstrated that price-gouging American patients continues to be a profit-generator for Big Pharma. All three Big Pharma companies surpassed earnings […]

Big Pharma Watch: New Study Finds Big Pharma Hiked Prices on 20 of Top 25 Part D Drugs at Rates Three to Nine Times Higher Than Inflation

10-22-2019 Blog Posts

In case you missed it, a new analysis from the Kaiser Family Foundation (KFF) found Big Pharma hiked the price of 20 of the top 25 Medicare Part D drugs at rates three to nine times the rate of inflation between 2016 and 2017. Top brand name price increases included: 7 percent for Lyrica 3 […]


10-8-2019 Blog Posts

In yet another example of how Big Pharma attempts to game the system, Bloomberg Government reports that six of the industry’s top brand name drug manufacturers “funneled more than $680 million into hundreds of nonprofits last year, including many now campaigning against federal legislation to tackle the rising cost of medicine.” And while donating to […]

New Study: Big Pharma Hikes Prices Without Improving Their Drugs

10-8-2019 Blog Posts

Unjustified Price Increases Cost Patients And Health Plans Billions Big Pharma repeatedly hikes prices on brand name drugs without making any improvements to those medications. That’s the finding of a new analysis conducted by the Institute for Clinical and Economic Review (ICER). The report found that drug companies hiked prices on seven popular drugs in […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.